Jeffrey Crippin

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Acute Liver Failure 63%
3. Hepacivirus 35%
4. Liver 31%
5. Hepatitis C 30%
6. Liver Diseases 25%
7. Transplant Recipients 23%
8. Fibrosis 22%
9. Chronic Hepatitis C 19%
10. Survival 19%
11. Transplants 19%
12. Hepatocellular Carcinoma 17%
13. Interferons 17%
14. End Stage Liver Disease 16%
15. Biliary Liver Cirrhosis 16%
16. Allografts 16%
17. Transplantation 16%
18. Sclerosing Cholangitis 14%
19. Acetaminophen 14%
20. MicroRNAs 12%
21. Ribavirin 12%
22. Hepatitis 11%
23. Recurrence 11%
24. Serum 10%
25. Therapeutics 9%
26. Organ Transplantation 8%
27. Immunosuppression 8%
28. Liver Cirrhosis 8%
29. Hepatitis B virus 8%
30. Graft Survival 8%
31. Liver Failure 7%
32. Immunity 7%
33. Autoimmune Hepatitis 7%
34. Hepatitis B 7%
35. Antiviral Agents 7%
36. Tissue Donors 7%
37. Vitamin D-Binding Protein 7%
38. Infections 6%
39. Wounds and Injuries 6%
40. Ursodeoxycholic Acid 6%
41. alpha-Fetoproteins 6%
42. Bone Diseases 6%
43. Cohort Studies 5%
44. Lamivudine 5%
45. Immunosuppressive Agents 5%
46. Virus Diseases 5%
47. Survival Rate 5%
48. Isoniazid 5%
49. Tacrolimus 5%
50. Chronic Hepatitis B 5%